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Abstract 
OBJECTIVE 
There is sparse evidence for suitable food substitutions for red and processed meat on risk of 
type 2 diabetes. We modelled the association between replacing red and processed meat with 
other protein sources and the risk of type 2 diabetes and estimated its population impact. 
RESEARCH DESIGN AND METHODS 
The European Prospective Investigation into Cancer (EPIC)-InterAct case-cohort included 
11,741 type 2 diabetes cases and a subcohort of 15,450 participants in eight countries. We 
modelled the replacement of self-reported red and processed meat with poultry, fish, eggs, 
legumes, cheese, cereals, yogurt, milk and nuts. Country-specific hazard ratios (HR) for 
incident type 2 diabetes were estimated by Prentice-weighted Cox regression and pooled using 
random-effects meta-analysis.  
RESULTS 
There was a lower hazard for type 2 diabetes for the modelled replacement of red and 
processed meat (50 g/day) with cheese (HR 0.90, 95% confidence interval 0.83–0.97; 30 
g/day), yogurt (0.90, 0.86–0.95; 70 g/day), nuts (0.90, 0.84–0.96; 10 g/day) or cereals (0.92, 
0.88–0.96; 30 g/day) but null for replacements with poultry, fish, eggs, legumes or milk. 
Assuming a causal association, replacing red and processed meat with cheese, yogurt or nuts 
could prevent 8.8%, 8.3% or 7.5%, respectively, of new cases of type 2 diabetes. 
CONCLUSIONS 
Replacement of red and processed meat with cheese, yogurt, nuts or cereals was associated 
with a lower rate of type 2 diabetes. Substituting red and processed meat by other protein 
sources may contribute to the prevention of incident type 2 diabetes in European populations. 
 
 
Type 2 diabetes is a major public health challenge and its prevalence is projected to increase 
from 463 million in 2019 to 700 million by 2045 (1). One key modifiable risk factor in the 
prevention of type 2 diabetes is diet (2). Most dietary recommendations to prevent type 2 
diabetes advise that intake of red and processed meat should be limited, mainly based on 
evidence from cohort studies (3–5), including the multi-country European Prospective 
Investigation into Cancer (EPIC)-InterAct study (6). However, few studies have quantified 
the risk associated with replacement of red and processed meat by other food sources of 
protein (5). Other food sources of protein in European diets include poultry, fish, cheese, 
yogurt, milk, eggs, legumes, nuts and cereals (7). A previous study reported that replacing red 
and processed red meat with poultry, low-fat dairy, whole grains or nuts was associated with 
a lower risk of type 2 diabetes in three US cohorts of health professionals (8). This study did 
not investigate different types of dairy products (cheese, yogurt, milk), eggs or legumes.  
We aimed to investigate the impact of replacing red and processed meat with other food 
sources of protein (poultry, fish, cheese, yogurt, milk, eggs, legumes, nuts and cereals) on the 
development of type 2 diabetes. Moreover, we estimated the population attributable fraction 
for replacements associated with lower rates of type 2 diabetes. Lastly, based on previous 
findings (9,10), we estimated the contribution of iron storage (serum ferritin) as a potential 
mediator.  
 
RESEARCH DESIGN AND METHODS 
The EPIC-InterAct Study 
Study population 
EPIC-InterAct is a case-cohort study nested within the EPIC cohort (11). A detailed 
description of the study design can be found elsewhere (12). In brief, the EPIC-InterAct study 
identified type 2 diabetes cases among study participants from eight countries (France, Italy, 
 
 
Spain, the United Kingdom, the Netherlands, Germany, Sweden and Denmark) included in 
EPIC with available blood samples (n=340,234; 3.99 million person-years of follow-up from 
1991-2007). After excluding prevalent cases of type 2 diabetes at baseline (n=548), the study 
included 12,403 verified cases of incident type 2 diabetes and 16,154 participants in a 
representative subcohort, including, by design, an overlap of 778 incident type 2 diabetes 
cases. After we excluded participants in the bottom and top 1% of the energy 
intake/requirement ratio (n=619) and those with missing information on dietary data (n=736), 
education (n=330), physical activity (n=385) and BMI (n=197), a total of 15,450 participants 
in the subcohort and 11,741 type 2 diabetes cases were included in this analysis 
(Supplemental Fig. S1). All participants gave written informed consent and the study was 
approved by the local ethics committees in the participating countries and the Internal 
Review Board of the International Agency for Research on Cancer.       
Dietary assessment 
Habitual dietary intake for the 12 months before entering the study was assessed using self- 
or interviewer-administered country-specific food frequency questionnaires (FFQs) or diet 
history interviews (11,13). Further information on dietary assessments methods and 
correlation coefficients for protein and food sources of protein from validation studies are in 
Supplemental Table S1. The questionnaires were used to estimate the average daily intake of 
foods and nutrients. A single 24h dietary recall was collected from an 8% random sample of 
participants from each country.  
We considered the following food sources of protein: red meat, processed meat, poultry, 
fish, cheese, yogurt, milk, eggs, nuts, legumes and cereals. Cereal consumption was included 
as this food group was the largest non-animal food source of protein in EPIC (7). Definition 
of individual foods groups are in Supplemental Table S2.  
 
 
Portion sizes were designated as 200 g/day for milk, 70 g/day for yogurt, 50 g/day for red 
and processed meat, poultry, fish, eggs and legumes, 30 g/day for cheese and cereals and 10 
g/day for nuts, all based on previously reported serving sizes or intake ranges from the EPIC-
InterAct study (6,14–16). As information on servings was not available for legumes and 
cereals, we used those in recent meta-analyses (17,18).  
Type 2 diabetes ascertainment 
Multiple sources of information from each EPIC study centre were used to ascertain type 2 
diabetes cases including self-report, linkage to primary-care, secondary-care, drug, hospital 
admissions and mortality data as described previously (12). Cases identified from only one 
independent source were verified through at least one other source, including medical 
records. Because cases in Denmark and Sweden were ascertained using local and national 
diabetes registers these cases were considered verified. Follow-up was censored at the date of 
diagnosis, loss to follow-up, death or 31 December 2007, whichever came first.  
Covariate assessment 
Data on lifestyle and medical history were obtained from self-administered questionnaires at 
baseline including education, physical activity, smoking and alcohol. Physical activity was 
classified according to the Cambridge Physical Activity Index. Validity of the index was 
assessed against objectively measured energy expenditure (19). Height, weight and waist 
circumference were measured by trained personnel using standardised protocols during a 
clinic visit at baseline in all study centres, except Oxford (UK) and centres in France which 
obtained self-reported measures. Waist circumference was not available in Umeå (Sweden). 
Body mass index (BMI) was calculated as weight (kilograms) divided by height (meters) 
squared. History of prevalent cancer, myocardial infarction, stroke, angina, hypertension or 
hyperlipidemia was based on self-report.  
 
 
At the baseline, clinic visit blood samples were collected and stored at -196°C (-150°C in 
Denmark and -80°C in Sweden) at the co-ordinating centre or local biorepositories. Serum 
(except for plasma in Umeå) ferritin, as a marker of body iron storage, was analysed at SHL-
Groep, Etten-Leur, the Netherlands, using Cobas (Roche Diagnostics, Mannheim, Germany) 
assays (electrochemiluminescence immunoassay sandwich principle) on a Roche Hitachi 
Modular P analyser. The assay range was 0.5-2000 µg/L. Cobas assays were also used to 
measure high-sensitive C-reactive protein (hs-CRP) (20).    
Statistical analysis 
Standard descriptive statistics were used to summarize baseline characteristics for the total 
subcohort and incident type 2 diabetes. We have previously reported the baseline 
characteristics of the study population across quintiles of meat intake in the subcohort (6). 
The modelled associations of replacing red meat with the other protein sources were 
estimated with Prentice-weighted Cox regression models. The models were fitted separately 
by country and were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) 
for the replacement of red and processed meat by other food sources of protein. Then, 
country-specific estimates were pooled using random-effects meta-analysis and between 
country-heterogeneity was quantified using the I2 statistic.  
We adjusted for a range of covariates in a series of models. Model 1 included age 
(timescale), study centre (2 to 6 centres in each country), energy intake (kcal/day; 
continuous), sex (stratified by baseline hazard function), education (none, primary school, 
secondary school, longer incl. university), physical activity (inactive, moderate inactive, 
moderately active, active), smoking status (never, former, current, unknown) and alcohol 
intake (g/day; two continuous terms for a non-linear relationship based on three-knots 
restricted cubic spline function). In model 2 we further adjusted for dietary variables 
including fruit, vegetables (excl. legumes), sweets, soft drinks, coffee, tea and intake of other 
 
 
dairy products (e.g. cream desserts and dairy creams) (all in g/day; continuous). In model 3 
(specified as the main model) we further adjusted for BMI (kg/m2; continuous). In a further 
model we also adjusted for self-reported history of hypertension (yes, no, unknown), self-
reported history of dyslipidaemia (yes, no, unknown) and waist circumference (cm; 
continuous).  
The modelled association of each food replacement was estimated as follows using 
multivariable-adjusted regression. We first obtained regression coefficients (i.e. log hazard 
ratios) per one serving/day for red and processed meat and each of the other food sources of 
protein (i.e. poultry, fish, cheese, yogurt, milk, eggs, legumes, nuts and cereals). Then, we 
calculated the difference between the two coefficients, accounting for their variance and 
covariance, and exponentiated the difference to estimate the hazard ratio for each specific 
replacement of interest (21). Analyses were also performed excluding participants who 
consumed <10g/day of red and processed meat. Additionally, replacements of red meat and 
processed meat were evaluated separately.  
To investigate sources of heterogeneity between countries, we performed separate 
analyses in Northern and Southern Europe. We were not able to differentiate between intake 
of refined and whole grains, therefore in an exploratory analysis we stratified the replacement 
of red and processed meat with cereals by high and low intake of dietary fibre from cereals 
divided at the median of the subcohort, i.e. 8 g/day. Based on previous findings (6), we also 
stratified the replacement of red and processed meat with poultry analysis by sex.  
One of the mechanisms by which a high intake of red and processed meat may be 
associated with development of type 2 diabetes is through its high content of haem iron (22). 
We compared substitution models with and without adjustment for ferritin, a marker of body 
iron storage, using a one-sided Wald-test (23), separately for model 2 and 3 (without and with 
adjustment for BMI, respectively) among those with measured ferritin levels. Because ferritin 
 
 
is an acute-phase reactant and could therefore be elevated due to systemic inflammation, we 
additionally adjusted model 3 for hs-CRP, a marker of systemic inflammation (24). To 
quantify the extent to which ferritin explained the lower incidence rate arising from each 
replacement, we calculated: [HRreplacement not adjusted - HRreplacement adjusted for ferritin]/[HRreplacement not 
adjusted - 1]. A bootstrapping procedure (1000 replicates) was used to derive 95% confidence 
intervals.  
In sensitivity analyses, we 1) excluded participants with cancer, myocardial infarction, 
stroke, angina, self-reported hypertension and/or hyperlipidaemia at baseline, 2) excluded 
cases that occurred during the first two years of observation, due to concerns about reverse 
causation, 3) excluded individuals with HbA1c levels ≥6.5% (equivalent to 48 mmol/mol) 
measured at the baseline visit, 4) applied regression calibration to all dietary intakes due to 
possible measurement error in self-reported dietary intakes. We regressed intakes from the 
24-h dietary recalls on those from the FFQs in a multivariable-adjusted linear mixed model 
with country as a random effect. The HRs were then corrected by dividing the log HRs by the 
regression dilution ratio. Uncertainty in the calibration model was accounted for by sampling 
a set of five values using a multiple imputation approach. Corrected log HRs and standard 
errors were calculated and pooled using Rubin’s rules (25). 5) We also estimated 
replacements per 5 g protein from each source of protein.  
We estimated the population attributable fraction for the modelled replacements associated 
with a lower hazard of type 2 diabetes in the subcohort, under the assumption of causality, to 
investigate how much of the incidence of type 2 diabetes could be preventable by replacing 
red and processed meat with another protein source. The population attributable fraction was 
calculated as the difference between the predicted incidence rate (IR) for the overall 
subcohort and the predicted IR for the relevant replacements divided by the overall incidence 
rate (i.e. [IRsubcohort - IRreplacement]/[ IRsubcohort]). All IRs were adjusted for model 3 covariates 
 
 
and 95% CIs were derived using a bootstrap procedure with 1000 replications. All analyses 
were performed in Stata 15.1 (StataCorp, College Station, TX, USA). 
 
RESULTS 
The median follow-up time was 12.3 years. Table 1 shows the baseline characteristics of the 
subcohort and cases of type 2 diabetes. Type 2 diabetes cases were older, more likely to be 
men, have a lower education level, be physically inactive, smoke, and have a higher BMI and 
higher levels of serum ferritin compared with subcohort participants. Those with type 2 
diabetes had a slightly higher intake of red and processed meat and soft drinks and a lower 
intake of yogurt, sweets and fruits. 
Modelled replacement of red and processed meat with cheese, yogurt, nuts or cereals was 
associated with lower hazard of type 2 diabetes (Fig. 1 and Supplemental Fig. S2). Replacing 
red and processed meat with fish also suggested a lower rate of type 2 diabetes (HR 0.91, 
95% CI 0.84–1.00; p=0.046) and a similar point estimate was observed for poultry, but with 
wider CIs (0.91, 0.77–1.07). Replacing red and processed meat with milk, eggs or legumes 
was not significantly associated with type 2 diabetes risk. Additional adjustment for BMI 
attenuated most of the associations with type 2 diabetes, particularly the replacement of red 
and processed meat with legumes (model 2: 0.88, 0.80–0.96 and model 3: 1.01, 0.86–1.19). 
Similar patterns of associations as in the main analysis were observed after excluding very 
low consumers of red and processed meat (n=739) (data not shown) and when red meat and 
processed meat were replaced separately (Supplemental Fig. S3). Replacing processed meat 
with fish was associated with a lower hazard of type 2 diabetes (0.82, 0.71–0.94), whereas 
replacing red meat with fish was not (0.95, 0.86–1.04). 
There was heterogeneity between countries for the replacement of red and processed meat 
with poultry or fish (Supplemental Fig. S2). This was not explained by European region (i.e. 
 
 
north and south Europe) (Supplemental Fig. S4). Stratification by sex for the replacement of 
red and processed meat with poultry showed associations in different directions for men and 
women: poultry (men: 0.74, 0.59–0.93; women 1.16, 0.89–1.52; p for interaction 0.04). After 
stratification of the replacement of red and processed meat with cereals by high or low cereal 
fibre, we found no substantial differences between strata (Supplemental Fig. S5). 
Adjustment for ferritin attenuated the estimated HRs for all replacement analyses, with 
and without adjustment for BMI (Supplemental Table S3). Further adjusting for hs-CRP did 
not change the results (data not shown). 22.1 to 31.8% of the lower incidence rate observed 
for replacement of red and processed meat with cheese, yogurt, nuts and cereals was 
explained by serum ferritin (Fig. 3).  
Across all sensitivity analyses a similar pattern of associations was observed as in the 
main analysis (Supplemental Fig. S6) except for replacement with 5 g protein/day from 
cereals, which was not associated with diabetes risk (0.99, 0.94–1.04) (Supplemental Fig. 
S7). The population attributable fraction for the modelled replacement of one serving/day of 
red and processed meat with one serving/day of cheese, yogurt or nuts was 7.5% to 8.8% of 
type 2 diabetes cases in our study (Table 2). For cereals, the confidence interval was wide and 
included zero.    
 
CONCLUSIONS 
In this large case-cohort study across eight European countries, we used substitution 
modelling and estimated that replacing red and processed meat with cheese, yogurt, nuts or 
cereals was significantly associated with a lower rate of type 2 diabetes whereas replacing red 
and processed meat with poultry, fish, milk, eggs or legumes was not. Mediation analysis 
suggested that these associations were partially mediated by body iron storage as assessed by 
serum ferritin levels. Assuming causality, 7.5 to 8.8% of the observed cases of type 2 
 
 
diabetes could have been prevented if all participants replaced one serving/day of red and 
processed meat with one serving/day of cheese, yogurt or nuts. 
This prospective case-cohort study included individuals from geographically diverse 
populations across Europe. By specifying modelled food substitutions, the results allow a 
clear interpretation for public health and healthful selection of other protein sources as 
alternatives to red and processed meat for the primary prevention of type 2 diabetes. The 
serving sizes in g/day were based on previous literature and study intake ranges. The 
difference in energy content between the substituted foods may leave an unspecified energy 
substitution (for instance, the energy difference between 50 g of red meat and 30 g of cheese) 
that must be compensated for by other foods not in the model. However, serving size 
information in g/day is likely to be more readily understood than information in units of 
energy percent or kcal/day. All replacements may not be applicable to a single meal-setting 
but rather to longer-term average replacements in the habitual diet. For instance, replacing 50 
g of red meat with 10 g of nuts in a single meal may not be realistic. Dietary intake 
information was obtained from cohort-specific semi-quantitative FFQs or diet history 
interviews across eight different European countries. This provided greater variation in 
intakes than in studies that included participants from a single country. Still, intake of nuts 
was generally low which highlights the importance of a cautious interpretation.  
A limitation of the current study is that the food substitutions were inferred based on a 
statistical model that compared individuals with different average intakes while no one 
actively changed their diet. Conducting randomized controlled trials of foods for long-term 
health endpoints such as type 2 diabetes is not practical, and in their absence well conducted 
prospective studies that not only assess associations of food intake but model food 
substitutions can be helpful. We also acknowledge the limitation of our use of a single 
measure of diet and covariates and we were not able to examine changes over time. 
 
 
Nevertheless, our results are consistent with those from studies modelling repeated measures 
of red and processed meat intake as either average intake or dietary changes (8,26). Self-
reported dietary measures are prone to error. While we observed similar patterns of 
associations after regression calibration against a single 24-hour recall, errors due to self-
reporting, covariate measurement errors and confounding due to unmeasured factors may bias 
our findings in either direction. Type 2 diabetes cases were verified in our study and the risk 
of misclassification was low. Analysis excluding undiagnosed diabetes at baseline showed 
similar patterns of associations.  
 There is limited evidence from prospective studies about the effects of replacing red and 
processed meat with other protein sources on incident type 2 diabetes. Pan et al. found that 
replacing red and processed red meat with nuts, low-fat dairy, whole grain, poultry and fish 
was associated with a lower risk of type 2 diabetes (8). We found that the HRs for replacing 
red and processed meat with fish or poultry were similar in magnitude to the estimates for 
cheese, yogurt, nuts and cereals but with wider CIs and not statistically significant. When 
replacing processed meat with fish, but not when replacing unprocessed red meat with fish 
we observed a lower rate of type 2 diabetes. Also, we found that replacing red and processed 
meat with poultry was associated with a lower diabetes rate in men, but not in women. The 
reasons for these differences by sex are unclear, but we may speculate that differences in 
preparation methods and types of red and processed meat as well as poultry and fish 
consumed by men and women in different countries may contribute, though we were unable 
to test this in our study. We found that replacing red and processed meat with fermented dairy 
products, such as yogurt and cheese, but not with milk, was associated with a lower rate of 
type 2 diabetes. Neither prior reports from US-based cohorts (8) nor our current study are 
able to clarify whether the type of dairy product (such as fermented or not) or specifically its 
nutrient content is more important for type 2 diabetes risk.  
 
 
To our knowledge, no previous study has investigated the association of replacing red and 
processed meat with eggs or legumes on the development of type 2 diabetes. Other cohort 
studies, that have not specified food substitutions, have suggested that intake of eggs was not 
associated with risk of type 2 diabetes in Europe or Asia, but positively associated with risk 
in the US, with significant heterogeneity by region (27). Legume intake was not associated 
with type 2 diabetes in a recent umbrella review of meta-analyses (5), although the 
definitions of legumes varied substantially across studies, which is also the case across our 
study centres. Overall, due to the low intake of legumes in some countries, most estimates 
were, however, imprecise and further research is needed. 
There is consistent evidence from cohort studies linking whole grains to a lower risk of 
type 2 diabetes (18), but in the current study we were not able to differentiate between the 
intake of refined and whole grains. In an exploratory analysis stratifying the study population 
by cereal fibre, we found no substantial differences between strata. This could be a reflection 
of the absence of an association between refined grain and type 2 diabetes in this study, as in 
some other populations (18). When replacing 5 g protein from red and processed meat with 5 
g protein from cereals we found no association, suggesting that other nutrients in cereals, like 
dietary fibre, may drive the observed association. Our results extend the previous findings in 
the US study to a European population and highlight that some, but not all, food sources of 
protein may be beneficial for type 2 diabetes risk as alternatives to red and processed meat. A 
caveat to this is that the point estimates for poultry and fish were similar to the other 
replacement foods’, but with less precision.  
In this study, we were able to investigate whether body iron stores, measured as serum 
ferritin, could mediate the association of replacing red meat with other sources of protein. 
Our results suggest that ferritin may explain up to 31.8% of the observed associations, 
although the associations were, in general, weak. This is in line with a previous finding that 
 
 
serum ferritin may partly mediate the association between intake of red meat and risk of type 
2 diabetes in the EPIC-Potsdam study (9). There are, however, alternative explanations for 
the potential benefits of substituting red meat with other protein sources. BMI could be 
regarded as a mediator. We found that most of our estimates were attenuated after adjustment 
for BMI as was also observed in a large Chinese cohort (28), and higher consumption of red 
and processed meat has also been associated with weight gain in the EPIC study (29). We 
only had a single measure of BMI and could not study weight change, but we pre-specified 
including baseline BMI as a potential confounder. Advanced glycation end products formed 
during the preparation of red and processed meat may increase body weight, inflammation 
and insulin resistance (30,31). Nitrates and nitrites, which are commonly found in processed 
meat, can be converted to nitrosamines which have been linked with insulin resistance and 
may be toxic to pancreatic beta-cells (30). Negative effects from preparation methods of other 
meat products, such as poultry or fish, might explain why these replacements were not 
associated with a lower risk of type 2 diabetes. Fermented dairy products like cheese and 
yogurt contain odd-chain fatty acids, ruminant trans fatty acids and probiotic bacteria, all of 
which have been hypothesised to have beneficial effects on glucose metabolism (32,33). 
Cereals, in our study consisting of both refined and whole grains, may lower the diabetes risk 
primarily through the intake of whole grains high in dietary fibre and phytochemicals with 
benefits on the production of short-chain fatty acids, improved insulin sensitivity and glucose 
control and anti-inflammatory effects (34). 
   Under the assumption of causal effects, stable dietary intakes and linear incidence rates, 
our estimate of the population attributable fraction suggested that 7.5% (95% CI 3.3% to 
11.3%) to 8.8% (3.1% to 13.6%) of observed type 2 diabetes cases could have been 
prevented if the population had replaced one serving/day of red and processed meat with one 
serving/day of cheese, yogurt or nuts. This is relevant for public health. Our study paid close 
 
 
attention to accounting for a range of potential confounding factors and addressed a number 
of potential biases. Our study was undertaken in meat consuming European populations and 
the results cannot, therefore, necessarily be generalised to non-European populations with 
different dietary habits. Although studies suggest that red and processed meat intake is 
positively associated with the development of type 2 diabetes (6), this may also depend on the 
consumption levels of other foods consumed in the diet, such as fibre- or calcium-rich foods, 
and whether or not red and processed meats are consumed within an overall healthy diet (35).  
In conclusion, this study suggests that the replacement habitually of one serving/day of red 
and processed meat with one serving/day of cheese, yogurt, nuts or cereals may be associated 
with a lower rate of development of type 2 diabetes. Replacing red and processed meat with 
other sources of protein may have public health impact for the prevention of type 2 diabetes. 
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Tables 
 
Table 1–Baseline characteristics of the EPIC-InterAct case-cohort study (n=26,460) 
 Total subcohort 
(n=15,450) 
  Type 2 diabetes cases 
(n=11,741) 
Characteristics Median (IQR)   Median (IQR) 
Age, years 53 (47-59)   56 (50-61) 
Women, % 62   50 
Lower education, % 41   51 
Physically inactive, % 24   30 
Smoker, % 26   28 
Body mass index, kg/m2 26 (23-28)   29 (26-32) 
Foods     
Red and processed meat, g/day 74 (46-108)   84 (53-121) 
   Red meat, g/day 38 (19-65)   43 (23-71) 
   Processed meat, g/day 28 (15-49)   32 (17-56) 
Poultry, g/day 16 (7-31)   16 (7-32) 
Fish, g/day 29 (15-52)   32 (16-55) 
Cheese, g/day 28 (14-51)   26 (12-49) 
Yogurt, g/day 26 (0-97)   20 (0-88) 
Milk, g/day 165 (45-301)   170 (47-321) 
Eggs, g/day 15 (7-25)   16 (7-28) 
Legumes, g/day 5 (0-23)   4 (0-20) 
Nuts, g/day 1 (0-3)   0 (0-2) 
Cereals, g/day 197 (140-273)   197 (137-273) 
Other dairy, g/day 6 (0-24)   5 (0-21) 
Sweets, g/day 71 (40-112)   65 (35-110) 
Soft drinks, g/day 3 (0-66)   10 (0-92) 
Fruit, g/day 193 (103-315)   182 (96-307) 
Vegetables (excl. legumes), g/day 155 (101-239)   149 (95-234) 
Coffee, g/day 270 (90-525)   287 (90-536) 
 
 
Tea, g/day 3 (0-197)   0 (0-119) 
Nutrients     
Total energy intake, kcal/day 2057 (1679-2515)   2084 (1685-2575) 
Alcohol*, g/day 8 (2-20)   8 (2-22) 
Alcohol abstainers, % 8   10 
Dietary fibre, g/day 22 (17-27)   22 (19-27) 
Serum ferritin, µg/l 82 (39-156)   132 (65-242) 
*Only in consumers, n=14,264 in subcohort and n=10,626 in cases. 
 
 
 
 
 
Table 2–Population attributable fraction for type 2 diabetes calculated 
in the subcohort (n total = 15,450) of the InterAct study 
Other food sources of protein to replace 
red and processed meat with* 
Population attributable 
fraction (95% CI)† 
  Cheese 8.8 % (3.1 to 13.6) 
  Yogurt 8.3 % (3.3 to 12.7) 
  Nuts 7.5 % (3.3 to 11.3) 
  Cereals 17.1 % (-6.7 to 33.3) 
*Serving sizes were 200 g/day for milk, 70 g/day for yogurt, 50 g/day for 
red and processed meat, poultry, fish, eggs and legumes, 30 g/day for 
cheese and cereals and 10 g/day for nuts. †Confidence intervals (CI) were 
derived from a bootstrap procedure to the difference between the predicted 
incidence rate for the overall subcohort and the predicted incidence rate for 
the relevant replacements divided by the overall incidence rate using 1000 
replicates. 
 
 
 
 
Figure legends 
 
Figure 1–The estimated association of replacing red and processed meat (per 50 g/day) with other food sources 
of protein and the incidence of type 2 diabetes in the EPIC-InterAct case-cohort study (n total = 26,460, n cases 
= 11,741). Country-specific estimates were obtained and combined using random effects meta-analysis. 
Adjusted for: age (underlying timescale), sex, centre, education, physical activity, smoking status, total energy 
intake, alcohol consumption, fruit, vegetables, sweets, soft drinks, coffee, tea, other dairy products and body 
mass index.  
 
Figure 2–Estimated % of the association between replacement of red and processed meat with other food 
sources of protein and risk of type 2 diabetes that is explained by serum ferritin (n total = 24,611, n cases = 
10,769). Confidence intervals (CI) were derived from a bootstrap procedure using 1000 replicates. Hazard ratios 
on which these estimates are based were estimated from Prentice-weighted Cox regression models adjusted for 
age (underlying timescale), sex, centre, country, education, physical activity, smoking status, total energy intake, 
alcohol consumption, fruit, vegetables, sweets, soft drinks, coffee, tea, other dairy products and body mass index. 
Serving sizes were 70 g/day for yogurt, 50 g/day for red and processed meat, 30 g/day for cheese and cereals and 
10 g/day for nuts. Estimated % of association explained calculated by: ((HRwithout – HRwith) / (HRwithout – 1))*100. 
 
  
